A randomized multicenter phase II trial to evaluate the safety and efficacy of vaccination with folate receptor alpha (FRa) peptides admixed with GM-CSF as an adjuvant versus GM-CSF alone in patients with platinum-sensitive ovarian cancer (EOC) Meeting Abstract

  

Authors:	O'Cearbhaill, R. E.; Konner, J. A.; Block, M. S.; Potts, J.; Garrett, G.; Kenney, R.; Wenham, R. M.; TPIV200 Ovarian Cancer Study Group
Abstract Title:	A randomized multicenter phase II trial to evaluate the safety and efficacy of vaccination with folate receptor alpha (FRa) peptides admixed with GM-CSF as an adjuvant versus GM-CSF alone in patients with platinum-sensitive ovarian cancer (EOC)
Meeting Title:	56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	38
Issue:	15 Suppl.
Meeting Dates:	2020 May 29-31
Meeting Location:	Virtual Conference
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2020-05-20
Language:	English
ACCESSION:	WOS:000560368302465
PROVIDER:	wos
DOI:	10.1200/JCO.2020.38.15_suppl.6040
Notes:	Meeting Abstract: 6040 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/172950